men

Dennis Rodman explodes onto scene as Jordan gets first chip in Netflix documentary series

The latest instalment of The Last Dance shows us the Michael Jordan we know and love, as well as some outlandish antics from Dennis Rodman, including a team-sanctioned mid-season trip to Las Vegas.




men

Unequal pay claim for US women's football team thrown out in court

The reigning champions of the Women's World Cup have the equal pay elements of their multiple-claims lawsuit against the United States Soccer Federation tossed out by a federal judge.




men

Five men in their 20s charged with esports match fixing

Five men are charged with match fixing offences — some of which carry penalties of up to 10 years in jail — as part of the first Australian criminal investigation into esports.




men

Fee-free models could help women's football flourish in Australia

With many families getting priced out of junior football, one club in Perth is waiving fees, and it could signal a new direction for grassroots sport in Australia, writes Samantha Lewis.




men

'Unfortunate mistake': Ratepayers to fork out for $70,000 soccer pitch measurement blunder

Residents in the Adelaide Hills will cover the cost of an "unfortunate" planning error involving state soccer authorities which has led to construction of smaller pitches than intended in original plans.




men

New York attorney general's office questioned NBC News employees on sexual harassment

Former anchor Linda Vester and others have been called in.




men

Commentary: U.S. should build a memorial 'plague column' for COVID-19, but where? Hint: Trump

Sculptures commemorating plagues were common in Europe. Our art critic suggests America could build its own, and Trump provides inspiration for where.




men

How accurate is 'Mrs. America's' portrayal of Republican women? We investigated

What Hulu's 'Mrs. America' gets right and wrong about Republican congresswoman Jill Ruckelshaus and evangelical activist Lottie Beth Hobbs in Episode 6.




men

Gamergate: Videogame industry speaks out against harassment


‘Gamergate’ controversy shines spotlight on the ugliest part of gaming culture.




men

$8-billion effort aims to speed development of coronavirus vaccines and treatments

The World Health Organization joined with global leaders to accelerate production of vaccines and treatments aimed at stamping out the coronavirus.




men

Navy recommends reinstatement of fired carrier captain

Officials say the top Navy officer has recommended the reinstatement of the aircraft carrier captain fired for sending an email pleading for faster action to protect his crew from a coronavirus outbreak.




men

Supreme Court declines to make 2nd Amendment ruling in New York gun case

Gun rights advocates had hoped Supreme Court would uphold a right to carry a gun in public, but justices said the case was moot.




men

'It's too soon': In small towns and big cities, Georgia's experiment in reopening moves slowly

A week after Georgia Gov. Brian Kemp plunged Georgia into the middle of a national social experiment — rolling back restrictions on businesses in an effort to restart the economy after a monthlong shutdown to halt the spread of COVID-19 — some restaurants, salons and tattoo parlors remain shuttered. Most that are opening are proceeding cautiously.




men

Drugs for heartburn, gout and depression now being tested as coronavirus treatments

The search for existing drugs that may help treat coronavirus infections now has researchers testing the heartburn drug Pepcid, among others.




men

Hospitals prepare for wave of mental health disorders among their workers

As many as 20% to 25% of healthcare workers in hard-hit areas, experts say, are likely to develop disorders such as anxiety, depression or post-traumatic stress.




men

Commentary: Evaluating risk and medical treatment in the time of coronavirus

Risk guides much of our medical care system. COVID-19 is showing us, unless we have developed immunity, we are all at risk.




men

Coronavirus: US unemployment claims hit 33.3 million amid virus

Data shows roughly one-fifth of the US workforce has filed for unemployment benefits since mid-March.




men

Christine McGuinness says lockdown has stopped arguments with husband Paddy

The Real Housewives star says lockdown has brought her closer to husband Paddy




men

Ongoing unraveling of a continental fauna: Decline and extinction of Australian mammals since European settlement [Environmental Sciences]

The highly distinctive and mostly endemic Australian land mammal fauna has suffered an extraordinary rate of extinction (>10% of the 273 endemic terrestrial species) over the last ∼200 y: in comparison, only one native land mammal from continental North America became extinct since European settlement. A further 21% of Australian...




men

FDA AMENDS THE DEFINITION OF “BIOLOGICAL PRODUCT” AND PREPARES FOR THE CONCLUSION OF A DECADE-LONG TRANSITION PERIOD

By Jennifer A. Davidson and Justine E. Johnson On February 21, 2020, FDA published a final rule that, effective March 23, 2020, amends the regulatory definition of “biological product” consistent with the statutory definition under the Biologics Price Competition and Innovation Act of 2009 (BPCIA), as amended by the Further Consolidated Appropriations Act, 2020 (FCAA),

The post FDA AMENDS THE DEFINITION OF “BIOLOGICAL PRODUCT” AND PREPARES FOR THE CONCLUSION OF A DECADE-LONG TRANSITION PERIOD appeared first on Kleinfeld Kaplan & Becker LLP.




men

It’s Not Always Easy Being Green – Lawsuit Related to “Recyclable” Claims Highlights Risks Related to Environmental Benefit Claims

By: Jacqueline Chan and Vanessa Fulton Consumers are increasingly demanding environmentally-friendly products and packaging.  Driven by this increased demand and desire to create positive environmental change, companies are working hard to shift to more sustainable materials and packaging and seeking to communicate such efforts to consumers through product labels and advertising.  “Recyclable.”  “Biodegradable.”  “Made of

The post It’s Not Always Easy Being Green – Lawsuit Related to “Recyclable” Claims Highlights Risks Related to Environmental Benefit Claims appeared first on Kleinfeld Kaplan & Becker LLP.




men

FDA ISSUES FINAL RULE ON GRAPHIC WARNINGS FOR CIGARETTE PACKAGES AND ADVERTISEMENTS

By: Stacy Ehrlich and Justine E. Johnson On March 18, 2020, the Food and Drug Administration (FDA) published a final rule (21 C.F.R. Part 1141) requiring textual and graphic health warnings to be included on all cigarette packages and advertisements.[1]  FDA simultaneously published two related guidance documents: (1) Required Warnings for Cigarette Packages and Advertisements,

The post FDA ISSUES FINAL RULE ON GRAPHIC WARNINGS FOR CIGARETTE PACKAGES AND ADVERTISEMENTS appeared first on Kleinfeld Kaplan & Becker LLP.




men

Indian analytical instruments industry expects low govt funding & curtailed Capex in post─COVID─19 phase




men

DCGI grants approval to PGIMS, Rohtak to start clinical trials on BCG vaccine for treatment of COVID─19




men

PPE suppliers providing unauthentic certificates to buyers including govt procurement agencies




men

DCGI directs state DCs to take stock of issues in procurement & prices of HCQ, azithromycin and paracetamol APIs




men

Health ministry releases guidelines on management of COVID─l9 suspect or confirmed cases in govt earmarked railway coaches




men

ICMR notifies NIMHANS as mentor institution for RT─PCR test protocol for COVID─19




men

Allmpus Labs to focus on increasing R&D in new drug discovery and development




men

Soft Actuator and Sensor for Underactive Bladder Treatment

Researchers at the National University of Singapore have developed a soft sensor and actuator to monitor bladder volume and help empty it on-demand. The device is intended to be implanted on the bladder surface during a surgical procedure to treat patients who cannot completely empty their bladders voluntarily. Patients can suffer from an underactive bladder […]




men

Survey suggests manufacturers need more support from the government

Small to medium-sized (SME) manufacturers are calling for greater and faster financial support from the government as they confront plummeting sales, production volumes, and the prospect of job cuts amid the ongoing Covid-19 pandemic.




men

FDA to Review Second Long-Acting Opioid Treatment (FDA</em>)

Braeburn Pharmaceuticals' CAM2038 gets positive FDA review




men

Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR

 Earlier today, the United States Supreme Court issued its opinion in the appeal of Stanford University against Roche Diagnostics. This case is of significant interest to the Biotechnology Industry Organization (BIO), Association of American Universities (AAU), American Council on Education (ACE), Association of Public and Land-grant Universities (APLU), Association of University Technology Managers (AUTM), and […]




men

BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act

by Stephanie D. Fischer BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act.  The letter is posted on our website and the text is below: “On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for your Manager’s Amendment […]




men

Newron drops development of sarizotan in Rett syndrome

The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints




men

Menarini to buy Stemline for up to $677 million

The move will establish Menarini's presence in the US biopharma market




men

ICR welcomes new advanced prostate cancer treatment guideline

NHS England has expanded access to targeted hormone therapies for advanced prostate cancer




men

Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M

Stemline Therapeutics, whose drug for a rare, aggressive type of acute leukemia was approved by the FDA about 18 months ago, has signed an acquisition deal with Italian biopharma Menarini Group. Stemline (NASDAQ: STML), a New York-based company, developed the first FDA-approved drug for blastic plasmacytoid dendritic cell neoplasm, or BPDCN. The drug, tagraxofusp (Elzonris) […]




men

Genmab announces newly-created Chief Financial Officer appointment

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named Anthony Mancini to the post. In this new role, he will oversee the company’s commercial strategies, including corporate development, business development and information technology functions

read more




men

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created role of Vice President, Thought Leader Engagement.

Gill had previously served at Alimera as its Senior Director, Thought Leader Liaison, before leaving the company for Novartis, where he most recently held the position of Associate Director, Thought Leader Liaison at Novartis US.

read more




men

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer.

The newly created role will see Dr McIntyre oversea the translational development of the company’s research-stage gene therapy programs. This includes regulatory filings, initiating early clinical studies and starting Investigational New Drug enabling preclinical studies.

read more




men

Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board

uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person's stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.




men

Paralyzed Patients Go From Wheelchairs To Walkers With Experimental Treatment

Two different groups of researchers have shown that electrical stimulation of the spinal cord, combined with months of intense training, can allow some people who have been paralyzed to regain some walking ability.




men

FDA update on COVID-19 actions and advisements

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.



  • Markets & Regulations

men

EPS taps CluePoints for trial management solution

The Japanese pharma development firm will harness risk-based quality management solutions to help sponsors improve trial quality and safety.




men

ERT launches patient-administered ECG assessment

The technology enables sponsors to continue gathering cardiac data for clinical trials without interruption or risk to patient safety.




men

Pharmaseal adds eTMF document storage to trial platform

The company has incorporated electronic trial master file document storage capabilities to its Engility clinical trial management platform.




men

Informa Connect-CBI’s 22nd Annual Medicaid and Government Pricing Congress

Informa Connect-CBI’s 22nd Annual Medicaid and Government Pricing Congress
May 19-21, 2020 | Orlando, FL
www.cbinet.com/medicaidandgovernment

Exclusive Offer: Register by April 10th and save $500* (mention promo code MDCDC5).

With a volatile healthcare system combined with an election year upon us, the stakes are incredibly high for life sciences manufacturers. Staying on the pulse of industry trends, policies and regulations has never been more critical. The 22nd Annual Medicaid and Government Pricing Congress delivers critical updates and industry best practices to effectively contract, report and comply with state and federal healthcare programs. Gain timely, up-to-the-minute insights on:
  • State Invoicing and Disputes
  • GTN Models
  • Innovative Contracting Strategies
  • State Price Transparency and Reporting Requirements
  • 340B Oversight and Compliance
  • Preparing, Negotiating and Implementing FSS Contracts
  • Bona Fide Service Fees and FMV
  • And many other critical topics
Download the complete program agenda.

The 2020 agenda features 75+ speakers and 50+ sessions customizable by company type and size, as well as 10 hours of dedicated networking. Bio/pharma, regulatory and government experts representing HHS, Pfizer, Daiichi Sankyo, Sobi, Maryland Department of Health, BMS, Jazz, Novartis, Amneal, J&J, Sunovion, Gilead, VA, Granard, Insmed, UCB, Alnylam, Louisiana Department of Health, AstraZeneca, CMS, CSL Behring, Astellas, Lilly, Oklahoma Healthcare Authority, Theravance, Indivior, Sandoz, Alvogen, Takeda, OIG, AMAG, Aimmune, Exelixis, South Dakota Department of Healthcare Services, Regeneron, Sun Pharma, Teva and many others are set to drive the dynamic dialogue.

Drug Channels readers can register today and use promo code MDCDC5 to save $500.

*Discount offer valid through 4/10/2020; applies to standard rates only and may not be combined with other offers, categories, promotions or applied to an existing registration. Offer not valid on workshop-only or non-profit registrations.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

        




men

Menopause Predisposes a Fifth of Women to Alzheimer's

Being female is a risk factor for Alzheimer’s. Why?

-- Read more on ScientificAmerican.com




men

Government Watchdog Chides FEMA for Lax Flood Enforcement

The agency fell well short of its goal of evaluating local flood control efforts every five years

-- Read more on ScientificAmerican.com